1. |
吴楠, 阎石, 吕超, 等.单病区组肺癌外科治疗的质控分析.中华胸心血管外科杂志, 2012, 28(10):609-613.
|
2. |
Graham EA, Singer JJ. Successful removal of an entire lung for carci-noma of the bronchus. JAMA, 1933, 101(2):1371-1374.
|
3. |
支修益, 李辉, 陈东红.早期非小细胞肺癌外科治疗进展.肿瘤研究与临床, 2010, 22(1):2-6.
|
4. |
Goldstraw P, Crowley J, Chansky K, et a1. The IASLC lung cancer staging project:proposals for the revision of the TNM stage grou-pings in the forthcoming(seventh)edition of the TNM classification of malignant tumours. J Thorac Oncol, 2007, 2(8):706-714.
|
5. |
Sugimura H, Nichols FC, Yang P, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg, 2007, 83(2):409-418.
|
6. |
Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation:a pooled analysis by the LACE Collaborative Group. J Clin Oncol, 2008, 26(21):3552-3559.
|
7. |
Tsim S, O'dowd CA, Milroy R, et al. Staging of non-small cell lung cancer(NSCLC):a review. Respir Med, 2010, 104(12):1767-1774.
|
8. |
Chansky K, Sculier JP, Crowley JJ, et al. The international association for the study of lung cancer staging project:prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol, 2009, 4(7):792-801.
|
9. |
支修益, 吴一龙, 马胜林, 等.原发性肺癌诊疗规范(2011年版).中国肺癌杂志, 2012, 15(12):677-688.
|
10. |
Silvestri GA, Gould M K, Margolis M L, et al. Non invasive staging of non-small cell lung cancer:ACCA evidenced-based clinical practice guidelines(2nd edition). Chest, 2007, 132(7):178S-201S.
|
11. |
支修益, 陈东红.非小细胞肺癌外科治疗现状和进展.首都医科大学学报, 2009, 30(3):298-305.
|
12. |
Shim SS, Lee KS, Kim BT, et al. Non-small cell lung cancer:pros-pective comparison of integrated FDG PET/CT and CT alone for preo-perative staging. Radiology, 2005, 236(3):1011-1019.
|
13. |
王长利, 江本元.低剂量螺旋CT联合PET筛查重度吸烟人群早期肺癌的研究-来自2年的临床试验结果.循证医学, 2009, 9(1):27-29.
|
14. |
Al-Damegh S. Fine needle aspiration of solitary pulmonary lesions. Eur J Radiol, 2001, 37(3):200-203.
|
15. |
Covey AM, Gandhi R, Brody LA, et al. Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol, 2004, 15(5):479-483.
|
16. |
International Association for the Study of Lung Caneer. Staging Manual in Thoracic Oneology. Orange Park:Editorial Rx Press, 2009.56-66.
|
17. |
陈东红, 支修益.肺癌新TNM分期系统解析及外科治疗策略.肿瘤研究与临床, 2010, 22(1):11-15.
|
18. |
Van Schil PE, Hendriks JM, Hertoghs MA, et al. Current surgical treatment of non-small-cell lung cancer. Expert Rev Anticancer Ther, 2011, 11(10):1577-1585.
|
19. |
Darling GE, Allen MS, Decker PA, et al. Randomized trial of medias-tinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1(less than hilar) non-small cell carcinoma:Results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg, 2011, 141(3):662-670.
|
20. |
Rusch VW, Crowley J, Giroux DJ, et al. The IASLC lung cancer staging project:proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol, 2007, 2(7):603-612.
|
21. |
Ludwig MS, Goodman M, Miller DL, et al. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest, 2005, 128(3):1545-1550.
|
22. |
Zhong WZ, Yang X, Bai JL, et al. Complete mediastinal lymphadenectomy:the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. Eur J Cardiothorac Surg, 2008, 34(1):187-195.
|
23. |
Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection improves survival in patients with stages Ⅱ and Ⅲa non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg, 2000, 70(2):358-366.
|
24. |
Manser R, Wright G, Hart D, et al. Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev, 2005, 25(1):CD004699.
|
25. |
Wu YL, Huang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung cancer, 2002, 36(1):1-6.
|
26. |
王长利, 岳东升, 张真发, 等.非小细胞肺癌1638例治疗及预后探讨.中华外科杂志, 2011, 49(7):618-622.
|
27. |
王长利, 朱建权.肺癌外科治疗研究进展.中国肿瘤临床, 2011, 38(24):1479-1483.
|
28. |
Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg, 1995, 60(3):615-623.
|
29. |
岳东升, 尤健, 苏延军, 等.淋巴结清扫数目与临床I期非小细胞肺癌的预后.中华胸心血管外科杂志, 2009, 25(4):221-222.
|
30. |
Hanagiri T, Baba T, Ichiki Y, et al. Sleeve lobectomy for patients with non-small cell lung cancer. Int J Surg, 2010, 8(1):39-43.
|
31. |
吴明拜, 张铸, 张力为, 等.气管隆凸、支气管、肺动脉成形术治疗肺癌.中国肺癌杂志, 2005, 8(1):42-44.
|
32. |
顾江魁, 葛阳, 陶立伟.支气管袖状成形肺叶切除术治疗中心型肺癌48例.中华全科医学, 2010, 8(4):444-445.
|
33. |
Inoue M, Minami M, Shiono H, et al. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter:pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement. Thorac Cardiovasc Surg, 2006, 131(5):988-993.
|
34. |
Decaluwe H, De Leyn P, Vansteenkiste J, et al. Surgical multimodality treatment for base line resectable stage ⅢA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Eur J Cardiothorac Surg, 2009, 36(3):433-439.
|
35. |
阚奇伟, 刘伦旭.肺癌手术中淋巴结清扫的现状与进展.中国胸心血管外科临床杂志, 2009, 16(3):214-217.
|
36. |
Matsuguma H, Yokoi K, Anraku M, et al. Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung:A predictor of lymph node metastasis. Thorac Cardiovasc Surg, 2002, 124(2):278-284.
|
37. |
周文, 张鹏.肺癌患者手术治疗中淋巴结清扫的原则与方式.中国肺癌杂志, 2009, 12(7):805-810.
|
38. |
Okada M, Tsubota N, Yoshimura M, et al. Prognosis of completely resected pN2 non-small cell lung carcinomas:What is the significant node that affects survival? J Thorac Cardiovasc Surg, 1999, 118(2):270-275.
|
39. |
Nohl HC, Chief. The Spread of Carcinoma of the Bronchus. London: Liyd Luke, 1996, 127(7):235-238.
|
40. |
Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissec tion imporves survival in patient with stageⅡandⅢa non-small cell lung cancer.Ann Thorac Surg, 2000, 70(2):358-366.
|
41. |
Kirby TJ, Mack MJ, Landreneau RJ, et al. Initial experience with video-assisted thoracoscopic lobectomy. Ann Thorac Surg, 1993, 56(6):1248-1253.
|
42. |
Leschber G, Holinka G, Linder A. Video-assisted mediastinoscopic lymphadenectomy(VAMLA)—a method for systematic mediastinal lymphnode dissection. Eur J Cardiothorae Surg, 2003, 24(2):192-195.
|
43. |
Watanabe A, Osawa H, Watanabe T, et al. Complications of major lung resections by video-assisted thoracoscopic surgery. Kyobu Geka, 2003, 56(11):943-948.
|
44. |
任华.外科手术在肺癌治疗中的地位.武警医学, 2011, 22(11):921-924.
|
45. |
Scott WJ, Allen MS, Darling G, et al. Video-assisted thoracic surgery versus open lobectomy for lung cancer:a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg, 2010, 139(4):976-983.
|
46. |
D'Amico TA. Video thoracoscopic mediastinal lymphadenectomy. Thorac Surg Clin, 2010, 20(2):207-213.
|
47. |
何建行, 刘会平, 杨运有.电视胸腔镜肺癌根治术5年临床疗效.中国胸心血管外科临床杂志, 2002, 9(1):29-31.
|